Fortis Life Sciences Acquires Abcore, A Leader in Nanobody Technologies
March 2, 2022
Extends company capabilities into nanobody and antibody discovery and development. WALTHAM, MA – Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics. Brian [...]
March 2, 2022
Woking, UK & London, UK — Global life sciences software company, IDBS, is excited to publicly announce the location of our new Surrey HQ office address in Woking. The move was driven by our company growth and need for additional workspace for our ever-expanding team of highly skilled, motivated and diverse associates. Our new office has [...]
NEW PARTNERSHIP IN SOUTH AFRICA
March 2, 2022
Think Global – Act Local! We are constantly expanding our global network to ensure that we can serve all our clients in the best possible way. As of January 1st, 2022, Helmut-Fischer signed a new distributor agreement with Advanced Laboratory Solutions (ALS) in South Africa. ALS has been supplying laboratory and scientific equipment for the last 25 [...]
10 years of Anton Paar ProveTec
March 2, 2022
Not only are we celebrating Anton Paar’s 100th anniversary this year, there are also some important birthdays to celebrate among our subsidiaries and producing sites. One of them is Anton Paar ProveTec: On March 1st, 2012, the company became part of Anton Paar. The former “Petrotest Instruments GmbH & Co. KG” in Dahlewitz, Germany, was founded [...]
BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners
March 2, 2022
Cologne BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life sciences research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to support the company’s worldwide [...]
Parallel Reactor Kit for Low Temperature Chemistry
March 2, 2022
Asynt has introduced a versatile new kit for labs conducting low temperature chemistry – the DrySyn SnowStorm MULTI Starter Kit. Developed as a useful addition to Asynt’s popular low temperature chemistry product range - the DrySyn SnowStorm MULTI Starter Kit enables users to perform parallel reactions from ambient to -30 ⁰C within a small footprint. [...]
March 2, 2022
NHS England and NHS Improvement sign two-year deal for QIAGEN’s HGMD bioinformatics HGMD (Human Gene Mutation Database) will be used at seven sites to aid interpretation of genomic data from next-generation sequencing (NGS) Deal highlights HGMD's lead role interpreting NGS results for inherited diseases NGS data from over 2.5 million clinical cases now analyzed and [...]
Gyros Protein Technologies introduces PurePep Sonata+ peptide synthesizer
March 2, 2022
Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, [...]
March 1, 2022
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments SAN JOSE, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the [...]
March 1, 2022
New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design Inspyra provides drug designers direct access to powerful AI capabilities, supporting established workflow CAMBRIDGE, UK: Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, [...]
